ReviewPharmaceutics2024

Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments.

Konstantinos Avgoustakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.